Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Chun-Chi Kao"'
Autor:
Ming-Han Hsieh, Tzu-Yu Kao, Ting-Hui Hsieh, Chun-Chi Kao, Cheng-Yuan Peng, Hsueh-Chou Lai, Hsing-Hung Cheng, Mao-Wang Ho, Chih-Yu Chi, Jung-Ta Kao
Publikováno v:
Journal of Microbiology, Immunology and Infection, Vol 57, Iss 6, Pp 840-853 (2024)
Background/Purpose: There are limited studies performing paired liver biopsies in chronic hepatitis C (CHC) patients treated with direct-acting antivirals (DAA). We aimed to investigate the predictors of liver fibrosis changes assessed by paired live
Externí odkaz:
https://doaj.org/article/124843e934d749ca8c837a4fd48f2d3e
Autor:
Ming-Han Hsieh, Tzu-Yu Kao, Ting-Hui Hsieh, Chun-Chi Kao, Cheng-Yuan Peng, Hsueh-Chou Lai, Po-Heng Chuang, Jung-Ta Kao
Publikováno v:
Therapeutic Advances in Chronic Disease, Vol 13 (2022)
Background: For chronic hepatitis C (CHC) patients completing pegylated interferon (PegIFN)-α/ribavirin therapy, long-term liver histological changes remain largely unexplored. Methods: This observational cohort study included 85 CHC patients comple
Externí odkaz:
https://doaj.org/article/89b55fad467842979781996aa71b9671
Autor:
Ming-Han Hsieh, Tzu-Yu Kao, Ting-Hui Hsieh, Chun-Chi Kao, Cheng-Yuan Peng, Hsueh-Chou Lai, Po-Heng Chuang, Jung-Ta Kao
Publikováno v:
PLoS ONE, Vol 15, Iss 12, p e0244293 (2020)
Background & aimsIt remains limited whether diabetes mellitus (DM) and hypertension (HTN) affect the prognosis of advanced hepatocellular carcinoma (HCC) treated with sorafenib. Our study attempted to elucidate the roles of DM/HTN and the effects of
Externí odkaz:
https://doaj.org/article/0c2fbbafc6e44ac193e0830ea91465ae
Autor:
Ting-Hui Hsieh, Jung-Ta Kao, Po-Heng Chuang, Ming-Han Hsieh, Chun-Chi Kao, Cheng Yuan Peng, Hsueh Chou Lai, Tzu-Yu Kao
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 12, p e0244293 (2020)
PLoS ONE, Vol 15, Iss 12, p e0244293 (2020)
Background & aimsIt remains limited whether diabetes mellitus (DM) and hypertension (HTN) affect the prognosis of advanced hepatocellular carcinoma (HCC) treated with sorafenib. Our study attempted to elucidate the roles of DM/HTN and the effects of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e7f83c3bfd978024d499d1badadbd9b
https://pubmed.ncbi.nlm.nih.gov/33382703
https://pubmed.ncbi.nlm.nih.gov/33382703
Autor:
Ming-Han Hsieh, Tzu-Yu Kao, Ting-Hui Hsieh, Chun-Chi Kao, Cheng-Yuan Peng, Hsueh-Chou Lai, Po-Heng Chuang, Jung-Ta Kao
Publikováno v:
Therapeutic Advances in Chronic Disease; 1/1/2022, p1-18, 18p